Mad in America

FEBRUARY 20, 2024

Stephenson and a team of researchers from various academic and pharmaceutical institutions, including the University of Virginia School of Medicine. Maelys Touya was an employee of Lundbeck LLC, and Lambros Chrones was an employee of Takeda Pharmaceuticals U.S.A., The study was authored by Judith J. Additionally, Anita H.

Pharmaceuticals 142

Pharmaceuticals Aging and mental health Insurance Healthcare 142

Mad in America

NOVEMBER 13, 2023

Schatzberg has served as a consultant to or received honoraria from Abbott, Bristol-Myers Squibb, Corcept Therapeutics, Forest Laboratories, Janssen, Eli Lilly, Merck, Mitsubishi Pharmaceuticals, Organon, ParkeDavis, Pfizer, Pharmacia–Upjohn, Sanofi, Scirex, SmithKline Beecham, Solvay, and Wyeth–Ayerst. 695 This is sickening.

Genetics and mental health 142

Genetics and mental health Aging and mental health Manufacturing Education 142

Mad in America

OCTOBER 10, 2023

I n the early 1960s, around the age of two, I experienced an accidental overdose. The incident occurred after one of my preschool-age siblings managed to use a kitchen chair to retrieve the tasty but very toxic medicine, open the bottle, and then give it to me believing the “candy medicine” would help their baby sister feel better.

Manufacturing 139

Manufacturing Pharmaceuticals Aging and mental health Nonprofits 139

Mad in America

OCTOBER 18, 2023

R ay Moynihan is an accomplished health journalist and author who has won several awards for his work. For the pharmaceutical industry, the bigger and wider those diseases, the more people who can be diagnosed, and the bigger your markets are. This applies in the mental illness world and everywhere in medicine.

Pharmaceuticals 145

Pharmaceuticals Manufacturing Healthcare Neurotransmitters and mental health 145